Market Overview

Options Brief: Cadence Pharmaceuticals


Shares of Cadence Pharmaceuticals (NASDAQ: CADX) are lower on the session by 1.15%, trading at $8.57.

Overall call volume is now running at 5.66x the daily average, with 77% of all calls traded being purchases on the offer. 2,005 contracts have traded on the session so far.

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates for use in the hospital setting.

Posted-In: Options


Related Articles (CADX)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Google Proves Mobile Growth is for Real Brilliant Pandora-Killer, Piracy Promoter, or Silly Startup Destined to Die?